Epigenomics AG Statistics

Total Valuation

Epigenomics AG has a market cap or net worth of EUR 806,818. The enterprise value is 11.77 million.

Market Cap	806,818
Enterprise Value	11.77M

Important Dates

The next estimated earnings date is Friday, May 29, 2026.

Earnings Date	May 29, 2026
Ex-Dividend Date	n/a

Share Statistics

Epigenomics AG has 876,976 shares outstanding. The number of shares has increased by 0.00% in one year.

Current Share Class	876,976
Shares Outstanding	876,976
Shares Change (YoY)	+0.00%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.00%
Float	622,111

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	33.62
PB Ratio	403.41
P/TBV Ratio	403.41
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-37.50
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.93, with a Debt / Equity ratio of 5,690.50.

Current Ratio	5.93
Quick Ratio	5.72
Debt / Equity	5,690.50
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -31,400.00% and return on invested capital (ROIC) is -2.10%.

Return on Equity (ROE)	-31,400.00%
Return on Assets (ROA)	-2.03%
Return on Invested Capital (ROIC)	-2.10%
Return on Capital Employed (ROCE)	-3.31%
Weighted Average Cost of Capital (WACC)	0.60%
Revenue Per Employee	8,000
Profits Per Employee	-104,667
Employee Count	4
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +4.31% in the last 52 weeks. The beta is 0.88, so Epigenomics AG's price volatility has been lower than the market average.

Beta (5Y)	0.88
52-Week Price Change	+4.31%
50-Day Moving Average	0.96
200-Day Moving Average	0.91
Relative Strength Index (RSI)	48.63
Average Volume (20 Days)	411

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Epigenomics AG had revenue of EUR 24,000 and -314,000 in losses. Loss per share was -0.36.

Revenue	24,000
Gross Profit	24,000
Operating Income	-382,000
Pretax Income	-314,000
Net Income	-314,000
EBITDA	-370,000
EBIT	-382,000
Loss Per Share	-0.36

Full Income Statement

Balance Sheet

The company has 414,000 in cash and 11.38 million in debt, with a net cash position of -10.97 million or -12.51 per share.

Cash & Cash Equivalents	414,000
Total Debt	11.38M
Net Cash	-10.97M
Net Cash Per Share	-12.51
Equity (Book Value)	2,000
Book Value Per Share	0.00
Working Capital	365,001

Full Balance Sheet

Cash Flow

Operating Cash Flow	-533,000
Capital Expenditures	n/a
Depreciation & Amortization	12,000
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-1,591.67%
Pretax Margin	-1,308.33%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Epigenomics AG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.00%
Shareholder Yield	-0.00%
Earnings Yield	-38.92%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 8, 2023. It was a reverse split with a ratio of 0.2.

Last Split Date	Dec 8, 2023
Split Type	Reverse
Split Ratio	0.2

Scores

Epigenomics AG has an Altman Z-Score of -10.77 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-10.77
Piotroski F-Score	1